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Received May 18, 2012; accepted November 1, 2012AbstractBackground: Advanced maternal age (AMA) is the most frequent indication for amniocentesis in predicting balanced reciprocal translocations,
and abnormal ultrasound findings are indications in predicting unbalanced reciprocal translocations; however, to date, no studies have focused on
Robertsonian translocations.
Methods: A retrospective review was conducted on 16,749 pregnant women who underwent midtrimester amniocentesis between January 1981
and December 2010. Robertsonian translocations were identified in 39 cases.
Results: The percentage of Robertsonian translocations in all amniocentesis cases was 0.23% (39/16,749); 31 were balanced and eight were
unbalanced. De novo abnormality occurred in 17 cases, or in 43.6% of all Robertsonian translocations. The two major indications for
amniocentesis with a diagnosis of Robertsonian translocations were AMA (41.0%, n ¼ 16) and a parent with abnormal karyotypes (18.0%,
n ¼ 7). The highest percentage of Robertsonian translocations was found in parents with abnormal karyotypes (2.8%, 7/252), but neither of the
indications were clearly superior for detecting de novo Robertsonian translocations.
Conclusion: Although AMA is an indication for amniocentesis in approximately two-fifths of cases with Robertsonian translocations, the
indication of parent with abnormal karyotypes was more likely to lead to the detection of non-de novo Robertsonian translocations, suggesting
that parents with abnormal karyotypes need careful prenatal consultation.
Copyright  2013 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Robertsonian translocations are structural chromosomal
anomalies that result from the fusion of two acrocentric
chromosomes. They are formed when the long arms of two
acrocentric chromosomes are translocated, ultimately forming
a single chromosome1; they have an estimated incidence ratehinese Medical Association. All rights reserved.
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in 1/500 healthy couples.2 The clinical significance of Rob-
ertsonian translocations is the increased risk of spontaneous
pregnancy wastage, infertility, and chromosomally unbalanced
offspring.3e6
The Robertsonian translocation is also referred to as a
“centric fusion” type of translocation, and is a fusion of the
entire long arms of two acrocentric chromosomes (chromo-
somes 13, 14, and 15 of the D group, and chromosomes 21 and
22 of the G group) after breakage at the centromeres.3 During
meiosis, these rearrangements form trivalents, the segregation
of which may result in nullisomic or disomic gametes for one
of the chromosomes involved in the rearrangement, and
consequently, a zygote with trisomy or monosomy for one of
the chromosomes involved.7 In humans, an individual with
what is called a “balanced” Robertsonian translocation shows
only 45 chromosomes, with the translocation chromosome
containing the two complete long arms of the two acrocentric
chromosomes involved.1 The short arms of the two trans-
located chromosomes are lost.1 The most common Rob-
ertsonian translocation is between chromosomes 13 and 14.7
The translocation between the D and G groups is responsible
for approximately 75% of all Robertsonian translocations, and
the potential live-born chromosomally unbalanced outcome of
this is translocation trisomy 13; there is also potential for
uniparental disomy for chromosome 14 following trisomy
rescue.8 The second most common Robertsonian translocation
is the translocation between the D and G groups (14 and 21),
and the potential live-born unbalanced outcome of this Rob-
ertsonian translocation between the D and G groups is trans-
location trisomy 21, resulting in Down syndrome.7
Although most of the short arms of the human acrocentric
chromosomes are lost after translocation, balanced Rob-
ertsonian translocation carriers are phenotypically normal,1
because the short arms mainly contain tandemly repeated
satellite DNA sequences and the ribosomal RNA genes, which
are present in all five pairs of acrocentric chromosomes.3
To date, only a few studies have addressed the indications
for amniocentesis to detect Robertsonian translocations, and
fewer studies have discussed the detection rate of the in-
dications for Robertsonian translocations.8,9 In addition, even
fewer studies have discussed de novo Robertsonian trans-
locations, because the majority of studies have focused on
Robertsonian translocation carriers.10 A recent large series
showed that advanced maternal age (AMA) was the most
frequent indication for amniocentesis in predicting balanced
reciprocal translocations, and abnormal ultrasound findings
were indications in predicting unbalanced reciprocal trans-
locations,11 but so far no studies have focused on Robertsonian
translocations.
However, for detecting Robertsonian translocations,
abnormal biochemical markers in maternal serum along with
abnormal ultrasound findings might be most important,
because these two were not only the most common indications
for amniocentesis but also had the highest detection rate for
chromosomal aberrations, including Robertsonian trans-
locations.9 Although the previously described data areavailable, we would like to share our data, based on a 30-year
experience in a single tertiary center,12,13 and use them to
study the indications and detection rates of Robertsonian
translocations in cases undergoing amniocentesis, which
would be of great value to couples who need further genetic
counseling.2. Methods
Data were obtained from amniocentesis records of the cy-
togenetic laboratory at Taipei Veterans General Hospital, a
tertiary medical center, between 1981 and 2010.12,13 The
detailed information on the indications for a prenatal diagnosis
of chromosomal abnormality with cytogenetic analysis has
been described elsewhere,14e17 which includes (1) AMA (i.e.,
if the mother will be 34 years at the expected date of
confinement), (2) abnormal chorionic villus sampling results,
(3) abnormal biochemical markers in the maternal serum, such
as screening maternal blood for Down syndrome (1/270), (4)
abnormal ultrasound findings, (5) intrauterine fetal death, (6)
family history of chromosomal abnormalities, (7) parent with
abnormal karyotype, (8) history of abnormal offspring at birth,
(9) radiation or medication exposure during pregnancy, and
(10) other nonspecific indications, such as anxiety, consan-
guineous marriage, and so on.
The frequencies of Robertsonian translocations and the de
novo-type of Robertsonian translocations in various in-
dications were estimated.3. Results
In this study, a total of 16,749 cases of amniocentesis were
analyzed, of which 39 were identified as Robertsonian trans-
locations. The highest proportion of Robertsonian trans-
locations was identified in cases with the indications of AMA
(41%, 16/39), followed by parental abnormal karyotypes
(18%, 7/39), other nonspecific indications (12.8%, 5/39),
detection of abnormal biochemical markers in maternal serum
(10.3%, 4/39), and abnormal ultrasound findings (10.3%, 4/39)
(Table 1).
There were 30 and nine balanced and unbalanced Rob-
ertsonian translocations, respectively (Table 1). Consistent
with the above data, AMA and parental abnormal karyotypes
were still the major indications for amniocentesis to detect
Robertsonian translocations, contributing to 46.7% (14/30)
and 20% (6/30), respectively, of the cases of balanced Rob-
ertsonian translocations, while other nonspecific indications
were involved in 10.7% of the cases. However, for cases of
unbalanced Robertsonian translocations, none of the in-
dications were significant, i.e., AMA, abnormal biochemical
markers in maternal serum, abnormal ultrasound findings, and
other nonspecific indications contributed equally to the
detection of unbalanced Robertsonian translocations (22.2% in
all). By contrast, parental abnormal karyotypes were not so
obvious in cases of unbalanced Robertsonian translocations
(Table 1).
Table 1
Frequency of Robertsonian translocations with different indications.
Case Abnormality case (number ¼ n/frequency ¼ %)
AMA Abnormal
CVS results
Abnormal
biochemical
markersa
Abnormal
ultrasound
findings
IUFD Family
historyb
Parental
abnormal
karyotypes
Previous
abnormal
offspring
Radiation or
medication
exposure
Others
Balanced 30 14 (46.7) 0 (0) 2 (6.7) 2 (6.7) 0 (0) 1 (3.3) 6 (20) 2 (6.7) 0 (0) 3 (10.7)
Unbalanced 9 2 (22.2) 0 (0) 2 (22.2) 2 (22.2) 0 (0) 0 (0) 1 (11.1) 0 (0) 0 (0) 2 (22.2)
Total 39 16 (41.0) 0 (0) 4 (10.3) 4 (10.3) 0 (0) 1 (2.6) 7 (18.0) 2 (5.1) 0 (0) 5 (12.8)
AMA ¼ advanced maternal age, that is, if the mother will be 34 years at the expected date of confinement; CVS ¼ chorionic villus sampling;
IUFD ¼ intrauterine fetal death.
a Abnormal biochemical markers in maternal serum such as screening of maternal blood for Down syndrome (1/270).
b Family history refers to family history of chromosomal abnormalities.
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in the detection of de novo balanced Robertsonian trans-
locations (58.3%, 7/12), and abnormal ultrasound findings
were a major indication in the detection of de novo unbalanced
Robertsonian translocations (40%, 2/5) (Table 2). The fre-
quencies of de novo Robertsonian translocations for every
individual indication, and that abnormal ultrasound findings
and family history had the highest frequency (Table 2) suggest
that fetuses with structural abnormalities that are detected
during the prenatal ultrasound examination should be carefully
evaluated, because these fetuses might have a higher risk of
the underlying chromosomal abnormality.
The overall percentage of Robertsonian translocations in all
amniocentesis cases was 0.23% (39/16,749) (Table 3). While
evaluating the frequency of Robertsonian translocations for all
indications, a parent with abnormal karyotype was found to
have the highest percentage (2.78%, 7/252) (Table 3). None of
the other indications had a detection rate above 1%. The fre-
quency of Robertsonian translocations in the AMA group was
low (0.15%), and that of abnormal biochemical markers in
maternal serum was also low (0.19%). Both were below the
average frequency for all cases with other indications for
amniocentesis. For detecting de novo Robertsonian trans-
locations with different indications for amniocentesis, both
abnormal ultrasound findings and family history had theTable 2
Frequency of de novo Robertsonian translocations with different indications.
De novo abn
AMA Abnormal
CVS
results
Abnormal
biochemical
markersa
Abno
ultras
findin
De novo case
Balanced 12 7 (58.3) 0 (0) 1 (9.1) 1 (9
Unbalanced 5 1 (20.0) 0 (0) 1 (20.0) 2 (4
Total 17 8 (47.1) 0 (0) 2 (11.8) 3 (1
De novo case/total case
Robertsonian 17/39 (43.6%) 8/16 (50%) 0 2/4 (50%) 3/4 (7
Balanced type 12/30 (40.0%) 7/14 (50%) 0 1/2 (50%) 1/2 (5
Unbalanced type 5/9 (55.6%) 1/2 (50%) 0 1/2 (50%) 2/2 (1
Robertsonian 17/39 (43.6%) 8/16 (50%) 0 2/4 (50%) 3/4 (7
AMA ¼ advanced maternal age, that is, if the mother will be 34 years
IUFD ¼ intrauterine fetal death.
a Abnormal biochemical markers in maternal serum such as screening of matern
b Family history refers to family history of chromosomal abnormalities.highest rates (0.41% and 0.55%, respectively; Table 3).
Consistent with the low frequency of Robertsonian trans-
location detection with AMA and abnormal biochemical
markers in maternal serum groups, the frequency of de novo
Robertsonian translocations was also low in both groups
(Table 3).
The most common de novo Robertsonian translocation
types involved chromosomes 13 and 14, accounting for 41.2%
of all de novo Robertsonian translocation types (Table 4). The
second most common type involved chromosome 21. In fact,
all de novo Robertsonian translocations involved chromo-
somes 13, 14, and 21.
4. Discussion
Consistent with previous domestic reports,8 AMA was a
main indication for amniocentesis, and there is no doubt that it
also accounted for a large number of Robertsonian trans-
location cases (n ¼ 14), although the detection rate was only
0.15%, which was significantly lower than the average of all
indications. In fact, AMA is always a main indication for
amniocentesis, but the detection rate for abnormality is low.8
Abnormal biochemical markers in the maternal serum was
another important indication for amniocentesis,18 accounting
for 10% of all cases undergoing amniocentesis. Although theormality case (number ¼ n/frequency ¼ %)
rmal
ound
gs
IUFD Family
historyb
Parental
abnormal
karyotype
Previous
abnormal
offspring
Radiation or
medication
exposure
Others
.1) 0 (0) 1 (9.1) 0 (0) 0 (0) 0 (0) 2 (18.2)
0.0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (20.0)
7.6) 0 (0) 1 (5.9) 0 (0) 0 (0) 0 (0) 3 (17.6)
5%) 0/0 1/1 (100%) 0/7 0/2 0/0 3/5 (60%)
0%) 0/0 1/1 (100%) 0/6 0/2 0/0 2/3 (66.7%)
00%) 0/0 0/0 0/1 0/0 0/0 1/2 (50%)
5%) 0/0 1/1 (100%) 0/7 0/2 0/0 3/5 (60%)
at the expected date of confinement; CVS ¼ chorionic villus sampling;
al blood for Down syndrome (1/270).
Table 3
Frequency of Robertsonian translocations and de novo Robertsonian translocations with different indications for amniocentesis.
Indication Case number (n) De novo Robertsonian translocations/Robertsonian
translocations
Case number (n) Frequency of abnormality (%)
AMA 10,970 8/16 0.07/0.15
Abnormal CVS results 25 0/0 0/0
Abnormal biochemical markers in maternal seruma 2090 3/4 0.14/0.19
Abnormal ultrasound findings 484 2/4 0.41/0.83
Intrauterine fetal death 50 0/0 0/0
Family historyb 183 1/1 0.55/0.55
Parent with abnormal karyotype 252 0/7 0/2.78
Previous abnormal offspring 792 0/2 0/0.25
Radiation or medication exposure 165 0/0 0/0
Others 1662 3/5 0.18/0.3
Total 16,749 17/39 0.10/0.23
AMA ¼ advanced maternal age, that is, if the mother will be 34 years at the expected date of confinement; CVS ¼ chorionic villus sampling.
a Abnormal biochemical markers in maternal serum such as screening of maternal blood for Down syndrome (1/270).
b Family history refers to family history of chromosomal abnormalities.
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Robertsonian translocations, the detection rate was below the
average of all indications.
By contrast, parents with abnormal karyotypes might not be
such an obvious indication for amniocentesis, but this indi-
cation accounted for the detection of 18% of all Robertsonian
translocations and resulted in a very high frequency of Rob-
ertsonian translocations (11-fold increased risk, 2.78%/
0.23%). The role of parent with abnormal karyotypes was
more significant and was confirmed in many studies,19 if we
consider it as an indication for detecting non-de novo Rob-
ertsonian translocations.
The other significant indication in the current study was
abnormal ultrasound findings, which accounted for only 2.9%
of all indications for amniocentesis, but 10.3% of all Rob-
ertsonian translocation cases with a fourfold increased risk
(0.41% vs. 0.10% and 0.83% vs. 0.23%, respectively). This
close correlation between abnormal ultrasound findings and
Robertsonian translocations is significant not only for the role
of abnormal ultrasound findings as an indication to detect
Robertsonian translocations,19 but also for the role of the
detection of Robertsonian translocations as a need for high-
resolution prenatal ultrasound examinations. In a study of a
northern Taiwan population, the frequency of all Robertsonian
translocations and de novo Robertsonian translocations in
12,468 amniocentesis specimens was 0.085% and 0.016%,
respectively.17 However, the major congenital anomaly rates
of inherited and de novo chromosome rearrangements were
1.96% and 6.66%, respectively, which were significantlyTable 4
Frequency of de novo Robertsonian trans-
location types.
Types Number (%)
13/14 7 (41.2)
14/21 2 (11.8)
13/21 1 (5.9)
21/21 5 (29.4)
15/21 2 (11.8)higher than the 1.4% congenital anomaly rate in the general
population,17 suggesting that the de novo chromosomal rear-
rangement contributes to an especially high risk of congenital
abnormalities, although we cannot identify the related map-
ping of genes and discover the function of the individual
genes.20 In this situation, the use of obstetric ultrasound may
be an opportunity to provide additional findings that may help
parents make decisions regarding their pregnancy.14,21
In the study, we reported the frequency of de novo Rob-
ertsonian translocation types. Consistent with the above find-
ings, the most common de novo Robertsonian translocation
types in this study also involved chromosomes 13 and 14
[rob(13q14q)], and accounted for 41.2% of all de novo Rob-
ertsonian translocation types. However, the second most
common form was rob(21q21q), which accounted for 29.4%
of all de novo Robertsonian translocations.
In conclusion, our study showed that only AMA was a
major indication for amniocentesis to diagnose Robertsonian
translocations; however, a parent with abnormal karyotype and
abnormal ultrasound findings may be more important as in-
dications for amniocentesis to detect Robertsonian trans-
locations, because parent with abnormal karyotype showed the
highest rate of detection of Robertsonian translocations, and
abnormal ultrasound showed the highest rate of detection of de
novo Robertsonian translocations. Both conditions should be
carefully monitored and further genetic testing should be
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